Joan Montero, PhD
Head Of Science
Biomarkers & Drugs
Dr. Joan Montero is an Instructor in Medicine at Dana-Farber Cancer Institute, a Harvard Medical School affiliated hospital. As a scientist, Dr. Montero has always been interested in the process of programmed cell death because it can explain why some therapies are not effective in treating cancer patients.
His most recent work has been directed at designing diagnostic tools for predicting how cancer cells will respond to chemotherapy. He developed a new functional predictive biomarker to predict chemotherapy response in patient biopsies and personalize cancer therapy in many types of cancer at the Letai Lab – Dana-Farber Cancer Institute; this technology has been patented by Dana-Farber Cancer Institute.
Dr. Montero earned his PhD at the University of Barcelona and has published more than 15 articles in international peer-reviewed journals, including a Cell publication. He has received many awards during his scientific career including the Spanish National Award for Oncology Research.
Dr. Montero is a motivated cancer researcher with a strong background in molecular biology, preclinical research, cell-based assays, biomarkers and discovery of novel anti-cancer therapies. He is a team player with an entrepreneurial spirit and one clear goal: to find new cures for kids with cancer.